Reuters: Serum Institute to boost production of COVID-19 vaccine doses to 200 million
“Serum Institute of India will make up to 200 million COVID-19 vaccine doses for poorer countries, including India, next year, as the Bill & Melinda Gates Foundation and GAVI vaccines alliance have doubled their funding, the company said on Tuesday. The extra funds will help Serum boost manufacturing of the vaccine candidates from AstraZeneca Plc and Novavax Inc, for delivery under the COVAX scheme as early as the first half of 2021. The collaboration takes forward an initial agreement signed in August by Serum, GAVI, and the Gates Foundation for 100 million doses to be priced at a maximum of $3 each…” (Mitra, 9/29).